Skip to main content
Fig. 2 | Inflammation and Regeneration

Fig. 2

From: A human induced pluripotent stem cell model from a patient with hereditary cerebral small vessel disease carrying a heterozygous R302Q mutation in HTRA1

Fig. 2

Characterization of SM9-1 iPSCs. a Morphology of the established iPSC line SM9-1 (left panel: feeder-free condition, right panel: on-feeder condition). Scale bar, 100 μm. b PCR analysis for the detection of remaining oriP/EBNA1-based reprogramming vectors. c Karyotype analysis of SM9-1 iPSCs. d Sanger sequencing of the targeted mutation site of HTRA1 gene (c.905G>A, p. R302Q, heterozygous) in SM9-1 T lymphocytes and SM9-1 iPSCs

Back to article page

Inflammation and Regeneration

ISSN: 1880-8190

Contact us